Shay Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-25,000
Closed -$2.89M 465
2023
Q3
$2.89M Buy
25,000
+8,550
+52% +$919K 0.41% 48
2023
Q2
$1.69M Sell
16,450
-4,794
-23% -$506K 0.24% 63
2023
Q1
$2.32M Buy
+21,244
New +$2.35M 0.46% 43

Other funds holding HZNP

Shay Capital's HZNP Position: Q4 2023 in Review

Shay Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 25,000 shares — an estimated $2.89M sold.

Shay Capital first reported a position in HZNP in Q1 2023 and held it in 3 quarters. The position peaked at $2.89M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Shay Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Shay Capital sold 25,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.89M.
  • Shay Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023 and held it in 3 quarters.
  • Shay Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.89M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Shay Capital's 13F filing for Q4 2023, filed 14 Feb 2024.